VERIFIEDMint Companies·13 Jul 2026neutral

Mylan launches block deal to sell minority stake in Biocon for up to $363 million

AI Summary

·Mylan, through its Viatris arm, is launching a block deal to sell its minority stake in Biocon.
·The deal aims to offload 92 million equity shares.
·This move represents a financial exit for Mylan following biosimilar asset integrations.